Ken Fisher Denali Therapeutics Inc. Transaction History
Fisher Asset Management, LLC
- $243 Billion
- Q3 2024
A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Fisher Asset Management, LLC holds 547,331 shares of DNLI stock, worth $11.4 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
547,331
Previous 478,108
14.48%
Holding current value
$11.4 Million
Previous $11.1 Million
43.62%
% of portfolio
0.01%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding DNLI
# of Institutions
227Shares Held
119MCall Options Held
60.6KPut Options Held
48.4K-
Baillie Gifford & CO13.3MShares$278 Million0.3% of portfolio
-
Black Rock Inc. New York, NY13.2MShares$275 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.2MShares$233 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA10.7MShares$224 Million0.06% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.91MShares$165 Million0.05% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $2.8B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...